6572 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
PlexBio Co., Ltd. engages in research, development, manufacture, and sale of medical testing equipment and reagents. Its products include in vitro diagnostic companion diagnostic kits, detection and genotyping diagnostic kits, nucleic acid extraction kits, and life science and research reagent kits. It also offers fluorescent analyzers, code processors, molecular assay and immunoassay automation systems, and trio nucleic acid extraction systems. The company founded on December 17, 2009 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6572 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company